United States:
Healthcare Weekly Preview From ML Strategies – Week Of June 12, 2017
To print this article, all you need is to be registered or login on Mondaq.com.
As we gear up for a busy week in Washington, D.C., our
colleagues at ML Strategies have
provided a Health Care Weekly Preview. This
week's preview describes upcoming hearing on safety net health
programs and prescription drug costs along with the progress
of the American Health Care Act. Stay tuned for additional
updates and analysis from ML Strategies.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
